Request Deal Involvement

Venrock Healthcare Capital Partners led a $107m Series C round in Lycia Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Melone Communications

pr advisors

Melone Communications

or

Principals

LYCIA THERAPEUTICS

target

LYCIA THERAPEUTICS

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

bidder

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

MARSHALL WACE

bidder

MARSHALL WACE

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

REDMILE GROUP

bidder

REDMILE GROUP

RTW INVESTMENTS

bidder

RTW INVESTMENTS

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

bidder

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Venrock Healthcare Capital Partners led a $107m Series C round in Lycia Therapeutics.